INFRAFRONTIER, the European Research Infrastructure for Modelling Human Diseases, is a non-profit organisation dedicated to advancing the understanding and treatment of diseases through cutting-edge in-vivo and in-vitro models. Operated by a network of over 20 leading biomedical research institutes, it empowers research on human health and disease while committing to excellence and prioritising animal welfare. By collaborating with other infrastructures, INFRAFRONTIER fosters global data sharing and plays a vital role in addressing major health challenges.
Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.